Codiţă Irina, Serban Roxana, Canton Amalia, Pistol Adriana
Institutul National de Cercetare şi Dezvoltare pentru Microbiologie şi Imunologie Cantacuzino.
Bacteriol Virusol Parazitol Epidemiol. 2010 Apr-Jun;55(2):145-50.
According to the resolution adopted by the Member States in the "Microbial threat" Conference, Copenhaga, 1988. antimicrobial resistance surveillance is one of the four pillars of the control strategy of this increasingly serious public health problem, coming together with the antimicrobial consumption surveillance, intersectoral actions and antibiotics prudent use promotion. Seventeen years ago, O'Brien and col. were describing the current degree of the antimicrobial resistance surveillance as follow: "There are no reliable data in this area--simply fragments of information and anecdotes that we use to draw an overall picture" (Diagnostic Microbiology and Infectious Diseases, 1992, 15.53S-60S). Ten years later, Morris and Masterton were showing that there were reports underlying the big volume of activity delivered in the field of antimicrobial resistance surveillance during that time, but there were no major changes in respect of the data quality (JAC,. 2002, 49, 7-10). According to the WHO definition, surveillance, as continuous and systematic process of data collection, data analysis and data reporting, is reaching it's scope only if it is able to provide information valuable for action. Though it is by excellence a type of surveillance based on the microbiology laboratory activity, antimicrobial resistance surveillance is not coming to be useful according to the WHO and EUCAST (European Committee for Antimicrobial Susceptibility Testing) acception without using the epidemiology methods in order to make possible the adoption of a clear strategy, starting from the definition of the type of information that we want to obtain. Pending on the scope and taking into account the preexisting premises for setting up a surveillance network, we need to select the appropriate surveillance methods, in respect of data and strains collection and storage, data reporting, appropriate denominators (population categories. admission days, patient days etc.), data stratifying etc. In Romania there are few data on antimicrobial resistance surveillance which could resist to a critical evaluation of representativity, reporting to adequate denominators, stratifying methodologies which would allow to follow trends, comparing data by wards, hospitals, counties, intercomparing data with other countries etc. Contacting the European Antimicrobial Resistance Surveillance System in 2001 was an initial modality to decrease the huge gap existing by that time, but could not remain the unique solution to develop in this direction. On the other hand, participating in the European Antimicrobial Resistance Surveillance System is enforcing the involvement of all implicated professional categories, improving logistic and interdisciplinary collaboration, in order to set up a systematic surveillance. We are supporting the initiative of a critical evaluation of the existing situation, as of setting up a surveillance strategy in accordance with the targetted goals, starting from the recent recommendations of WHO and ESCMID Antimicrobial Resistance Surveillance Study Group. This initiative could contribute, together with the participation in the European antimicrobial resistance surveillance program, to the efficient turning account of the resources and uncoordinated and sometimes redundant efforts of different working groups including prestigious microbiology, infectious diseases and epidemiology specialists.
根据1988年在哥本哈根举行的“微生物威胁”会议上成员国通过的决议,抗菌药物耐药性监测是这一日益严重的公共卫生问题控制策略的四大支柱之一,与抗菌药物消费监测、部门间行动以及促进抗生素谨慎使用共同构成该策略。十七年前,奥布赖恩及其同事对当前抗菌药物耐药性监测的程度描述如下:“该领域没有可靠的数据——只有一些零散信息和轶事,我们据此拼凑出一幅总体图景”(《诊断微生物学与传染病》,1992年,第15卷,53S - 60S页)。十年后,莫里斯和马斯特顿指出,当时抗菌药物耐药性监测领域有大量活动的相关报告,但数据质量方面没有重大变化(《抗菌化学治疗杂志》,2002年,第49卷,7 - 10页)。根据世界卫生组织的定义,监测作为数据收集、数据分析和数据报告的持续且系统的过程,只有在能够提供对行动有价值的信息时才达到其目的。尽管抗菌药物耐药性监测本质上是基于微生物实验室活动的一种监测类型,但根据世界卫生组织和欧洲抗菌药物敏感性试验委员会(EUCAST)的定义,如果不采用流行病学方法以便从我们想要获取的信息类型的定义出发制定明确策略,它就无法发挥作用。根据监测范围并考虑建立监测网络的现有前提,我们需要选择合适的监测方法,包括数据和菌株的收集与存储、数据报告、合适的分母(人群类别、入院天数、患者住院天数等)、数据分层等。在罗马尼亚,关于抗菌药物耐药性监测的数据很少能经得起对代表性、与适当分母的报告、能跟踪趋势的分层方法、按病房、医院、县进行数据比较以及与其他国家进行数据比对等方面的严格评估。2001年与欧洲抗菌药物耐药性监测系统建立联系是缩小当时存在的巨大差距的初步方式,但不可能一直是朝这个方向发展的唯一解决方案。另一方面,参与欧洲抗菌药物耐药性监测系统正在促使所有相关专业类别参与进来,改善后勤和跨学科合作,以建立系统的监测。我们支持对现有状况进行严格评估的倡议,即根据世界卫生组织和欧洲临床微生物学与传染病学会(ESCMID)抗菌药物耐药性监测研究组的最新建议,制定符合目标的监测策略。这一倡议与参与欧洲抗菌药物耐药性监测计划一起,有助于有效利用资源,并整合不同工作组(包括著名的微生物学、传染病学和流行病学专家)不协调且有时冗余的工作。